title: Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.
abstract: We assessed the safety and immunogenicity of hepatitis B vaccination among 40 human immunodeficiency virus-infected patients with isolated positivity for antibodies to hepatitis B core antigen. No baseline factors were found to be predictive of an anamnestic response, which occurred in 32.5% of the patients. The overall response rate among patients without an anamnestic response was 74.0% after 3-6 vaccine doses.
authors.affiliation: Service des Maladies Infectieuses et Tropicales, Hôpital Tenon, 75 970 Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Chakvetadze
authors.forename: Firouzé
authors.initials: F
authors.lastname: Bani-Sadr
authors.forename: Catherine
authors.initials: C
authors.lastname: Le Pendeven
authors.forename: François-Xavier
authors.initials: FX
authors.lastname: Lescure
authors.forename: Camille
authors.initials: C
authors.lastname: Fontaine
authors.forename: Tatiana
authors.initials: T
authors.lastname: Galperine
authors.forename: Laurence
authors.initials: L
authors.lastname: Slama
authors.forename: Philippe
authors.initials: P
authors.lastname: Bonnard
authors.forename: Philippe
authors.initials: P
authors.lastname: Mariot
authors.forename: Patrick
authors.initials: P
authors.lastname: Soussan
authors.forename: Gilles
authors.initials: G
authors.lastname: Pialoux
mesh_terms: D000328:Adult; D005260:Female; D015658:HIV Infections / Q000276:immunology*; D006510:Hepatitis B Antibodies / Q000097:blood*; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D007156:Immunologic Memory; D008297:Male; D008875:Middle Aged
chemical_list: D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D017325:Hepatitis B Vaccines